Angiotensin-receptor blockers: Benefits beyond lowering blood pressure

被引：4
|
作者：
Silverstein, RL
Ram, CVS
机构：
[1] Texas Blool Pressure Inst, Dallas Nephrol Associates, Dallas, TX 75235 USA
[2] Univ Texas, SW Med Sch, Dallas, TX USA
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 2005年 / 72卷 / 09期
关键词：
D O I：
10.3949/ccjm.72.9.825
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A number of controlled clinical trials provide evidence that angiotensin-receptor blockers improve the prognosis in a variety of conditions that place patients at high cardiovascular risk. The effect is more than one would expect from the effect of these agents on blood pressure alone. The results of some of these trials have expanded the indications for these drugs.
引用
收藏
页码：825 / 832
页数：8
相关论文
共 50 条
  • [41] Angiotensin-receptor blockers and cancer: urgent regulatory review needed
    Nissen, Steven E.
    LANCET ONCOLOGY, 2010, 11 (07): : 605 - 606
  • [42] Angiotensin-receptor blockers, type 2 diabetes, and renoprotection.
    Walser, M
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09): : 706 - 706
  • [43] Podocytes as a target for treatment with ACE inhibitors and/or angiotensin-receptor blockers
    Kriz, W
    KIDNEY INTERNATIONAL, 2004, 65 (01) : 333 - 334
  • [44] The potential economic impact of restricted access to angiotensin-receptor blockers
    Guertin, Jason R.
    Jackevicius, Cynthia A.
    Cox, Jafna L.
    Humphries, Karin
    Pilote, Louise
    So, Derek Y.
    Tu, Jack V.
    Wijeysundera, Harindra
    Rinfret, Stephane
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (03) : E180 - E186
  • [45] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers benefits outweigh the risks in COVID-19 hypertensive patients
    Ateya, Areej Mohamed
    Sabri, Nagwa A.
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (04) : 1873 - 1874
  • [46] Vascular benefits of angiotensin receptor blockers
    Voors, Adriaan A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (07) : 987 - 997
  • [47] Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis
    Mukamal, Kenneth J.
    Ghimire, Sanjay
    Pandey, Rudra
    Fiarman, Gale S.
    Gautam, Shiva
    ANNALS OF EPIDEMIOLOGY, 2012, 22 (10) : 747 - 750
  • [48] A COMPARISON OF BLOOD PRESSURE OUTCOMES ASSOCIATED WITH THE USE OF ANGIOTENSIN-RECEPTOR BLOCKERS (ARBS) IN PATIENTS SEEN PREDOMINANTLY IN PRIMARY CARE PRACTICES
    Biskupiak, J.
    Kim, J.
    VALUE IN HEALTH, 2009, 12 (07) : A314 - A314
  • [49] Significance of the vascular concentration of angiotensin II receptor blockers on the lowering mechanism of blood pressure in spontaneously hypertensive rats
    Takai, Shinji
    Jin, Denan
    Sakonjo, Hiroshi
    Takubo, Takayuki
    Nakanishi, Toyofumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 220P - 220P
  • [50] Comparison of angiotensin-receptor blocker and calcium channel blocker of morning blood pressure
    Eguchi, K
    Kario, K
    Ishikawa, J
    Hoshide, S
    Shimada, K
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 57A - 57A
12345